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Summary
Whole cells of living organisms, mainly of yeasts, have been used as reliable bio-
catalysts by synthetic organic chemists to perform redox reactions of various functional
groups. This review focuses on the potential of these whole cells to reduce acetophenones
and -unsaturated carbonyl compounds (aldehydes and ketones) furnishing relevant
chiral building blocks for fine chemicals and the pharmaceutical industries.
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Introduction
In 1987, the US Food and Drug Administration is-
sued a set of initial guidelines on the submission of new
drug applications, where the question of stereochemis-
try in the manufacture of drug substances was ap-
proached directly (1). The guidelines that were finally
released in 1992 stipulated that the action of each enan-
tiomer of a pharmaceutical product must be individu-
ally characterized. This regulation became a driving
force for researchers and pharmaceutical companies to
look for chemical or biochemical processes that result in
enantiomerically pure compounds. The chemical indus-
try is now turning more and more to enzymatic and fer-
mentation processes in order to obtain enantiomerically
pure aminoacids, aminoalcohols, amines, alcohols and
epoxides as intermediates for the pharmaceutical indus-
try and agrochemistry, where both a high degree of pu-
rity and large quantities of compounds are required (2).
The major advantage of whole living cells over iso-
lated NAD(P)H-dependent carbonyl reductases for use
in reduction processes is that the cells regenerate their
own cofactors. Further, they are easy to produce and
handle, and are of relatively low cost. This review fo-
cuses on the potential of whole cells of living organisms,
mainly yeast cells, to reduce acetophenones and -un-
saturated carbonyl compounds (aldehydes and ketones)
furnishing relevant chiral building blocks for fine chemi-
cals and the pharmaceutical industries.
Reduction of Acetophenone Derivatives
Acetophenone derivatives are probably the most
studied substrates used for enantioselective bioreduc-
tion to the corresponding alcohols. This reduction is me-
diated by whole cells of a variety of microorganisms.
The group of Mosher et al. (3) was one of the first to re-
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duce acetophenone using Saccharomyces cerevisiae to ob-
tain 1-phenyl-1-ethanol in reasonable yield and enantio-
meric excess (e.e.) (Scheme 1). Over the past few years,
many authors have used the products of enantioselec-
tive bioreductions of acetophenone derivatives as start-
ing materials for the synthesis of a wide type of opti-
cally active compounds.
In general, the reductions of acetophenone deriva-
tives follow Prelog’s rule (4) (the hydrogen transfer by
pseudo re-face), taking into account that the aryl group
is larger than the methyl group (Fig. 1). However, as
pointed out in the next section, some microorganisms
give products that have the opposite stereochemistry to
that predicted by Prelog’s rule.
Reduction of Acetophenones with
Substituents on the Benzene Ring
Various researchers have used a variety of microor-
ganisms to reduce acetophenones that have substituent
groups attached to the meta, ortho or para positions of
the benzene ring, obtaining the correspondent alcohols
in high e.e. (5–21). The velocity of this reaction is en-
hanced when electron withdrawing groups (EWG) are
attached to the para position of the aromatic ring and
slowed when electron donating groups (EDG) are at-
tached in this position (22,23). This observation agrees
with proposal that the hydride transfer from NADH or
NADPH to the ketone carbonyl carbon is mediated by a
dehydrogenase rather than by a radical mechanism
(24–29).
The enhacement and slowing effects may be ob-
served in Table 1, which shows data collected from re-
cent published works about the reduction of acetophe-
nones by various microorganisms. The electronic effect
can be observed when the substituents are in meta or
ortho positions, but some other types of effect, such as
the bulk of the substituent group and polar interactions
with the active site of the dehydrogenase, may become
predominant. It is interesting to note that some micro-
organisms contain a predominance of pro-R dehydro-
genases while others contain a predominace of pro-S
dehydrogenases (Scheme 2). This complementary en-
antioselectivity is very convenient, allowing synthetic
organic chemists to choose the best microorganisms for
use in their synthesis projects. In fact, the information
about the stereospecificity of each microorganism is so
important that fast-screening methodologies have been
developed in order to allow chemists to select the best
biocatalyst for a specific biotransformation.
Several workers have used these fast-screening me-
thodologies. Homann et al. (23) selected 14 microorgan-
isms in a screening involving 300 microorganisms for the
reduction of 4-substituted-acetophenone. Goswami et al.
screened about 100 microorganisms covering many spe-
cies of Candida, Pichia, Hansenula, Geotrichum, Rhodococ-
cus and Aureobasidium, for the stereospecific reduction of
-chloroketone (30). Chartrain et al. (31) screened more
than 300 microorganisms for the reduction of 12 phar-
maceutically relevant prochiral ketones, based on the
constructions and accessibility of a microbial library.
Patel et al. (18) found 19 microorganisms in a screen-
ing for the enantioselective reduction of 2-bromo-4-fluoro-
acetophenone, giving the corresponding (S)-alcohol in
excellent yield and e.e. In a screening of 416 microor-
ganisms for reductase activity, Carballeira et al. isolated
a new microorganism, Diplogelasinospora grovesii IMI
171018 that showed very high activity for reduction of a
cyclic ketone (21).
One of the disadvantages of ketone reductions in-
volving whole cells is that pro-S and pro-R dehydroge-
nases may be competing for the substrate and if the two
dehydrogenases have similar values of kcat/KM then the
alcohol produced will have low values of e.e. (34). A
number of strategies has been used to circumvent this
disadvantage, such as reduction of substrate concentra-
tion, which favors the enzyme with the highest value of
kcat/KM (35,36), the use of additives (37–40) and heat
treatment (41) to deactivate one of those enzymes. Mo-
lecular biology offers an alternative approach to elimi-
nating the catalytic activities of competing dehydroge-




























a: R = NO2
b: R = CN
c: R = Br
d: R = Cl
e: R = F
f: R = CH3
g: R = OCH3
h: R = OH
Scheme 2
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Table 1. Bioreduction of acetophenones with substituents in the benzene ring mediated by various microorganisms
Entry Ketone Microorganism Alcohol Yield/% e.e./% Ref.
1 p-Cl Rhodotorula glutinis 16740 (S) 80 >99 23
2 p-F " (S) 62 >99 "
3 p-Cl R. mucilaginosa 64684 (S) 75 >99 "
4 p-F " (S) 68 95 "
5 p-OCH3 " (S) 23 >99 "
6 p-Cl Yarrowia lipolytica 8661 (R) 86 >99 "
7 p-F " (R) 87 85 "
8 p-Me " (R) 77 73 "
9 p-OCH3 " (R) 61 >99 "
10 o-Cl Synechococcus sp. PCC 7942 (S) 24 96 32
11 m-Cl " (S) 37 100 "
12 p-Cl " (S) 34 96 "
13 o-F " (S) 28 100 "
14 m-F " (S) 14 100 "
15 p-F " (S) 2 100 "
16 o-Me Synechococcus sp. PCC 7942 (S) 8 100 "
17 m-Me " (S) 31 99 "
18 p-Me " (S) 6 100 "
19 o-OMe " (S) 10 100 "
20 m-OMe " (S) 19 100 "
21 p-OMe " (S) 4 100 "
22 p-OH Trichothecium sp. - - - 17
23 p-Cl " (R) 72 98 "
24 p-CH3 " (R) 45 90 "
25 p-OCH3 " - - - "
26 o-Cl Geotrichum candidum (S) 99 3 33
27 m-Cl " (R) 90 16 "
28 p-Cl " (R) 97 89 "
29 p-F " - - - "
30 o-CH3 " (R) 99 2 "
31 m-CH3 " (R) 89 21 "
32 p-CH3 " (R) 95 79 "
33 p-OCH3 " (R) 77 97 "
34 p-F Rhizopus arrhizus (S) 51 68 8
35 p-Cl " (S) 72 91 "
36 p-Br " (S) 62 94 "
37 p-I " (S) 59 96 "
38 p-OCH3 " (S) 58 10 "
39 p-CN " (S) 55 46 "
40 p-CH3 " (S) 72 72 "
nases. For example, a specific dehydrogenase can be
expressed in E. coli and whole cells of the engineered
strain can be used to reduce ketones (42,43). Expression
of the gene encoding NAD(P)H-dependent carbonyl re-
ductase in E. coli cells, together with the gene for glu-
cose dehydrogenase, which acts as cofactor regenerator,
allows the production of many chiral alcohols, as report-
ed by Shimizu and Ogawa (44).
Microbial resolution of racemic secondary alcohols
provides enantiomerically pure chiral alcohols, via oxi-
dation of only one enantiomer to the ketone. 1-Aryletha-
nols have been resolved by direct microbial de-racemi-
zation with either Geotrichum candidum (45) or Nocardia
corallina (46) and by a combined microbial oxidation/re-
duction with Bacillus stearothermophilus and Yarrowia li-
polytica (47). Nocardia corallina mediated the enantioselec-
tive oxidation of (3- or 4-substituted benzene)-1-ethanol
in reasonable yield and excellent e.e. (Scheme 3). Sub-
stituents at position–2 gave poor yield and e.e.
Reduction of Acetophenones with
Substituents at the -Carbon
The enantioselective reduction of acetophenones
that have a suitable group attached to the -carbon fur-
nishes valuable intermediates that can be used as chiral
building blocks in organic synthesis. Bioreduction of
-haloacetophenones 5a–c, mediated by Saccharomyces
cerevisiae, furnished halohydrins (R)-6a–c in 10–74 %
yield and 82–97 % e.e. (48) and the halohydrin (R)-6b
was used to prepare (R)-1-phenylethanolamines 8a–c via
chiral styrene oxide (Scheme 4) (49). The (R)-1-phenyl-
ethanolamine 8a was also synthesized by reduction of
-azidoacetophenone 9, mediated by Saccharomyces cere-
visiae immobilized on montmorillonite K10, giving the
corresponding azido alcohol 10 in 45 % yield and 97 %
e.e. This was reduced by H2/Pd-C to (R)-2-amino-1-phe-
nylethanol in 96 % yield and 97 % e.e. (Scheme 5) (50).
When -iodoacetophenone 5d was treated with Sac-
charomyces cerevisiae, dehalogenated products were ob-
tained (48). Haloacetophenones were used as mechanis-
tic probes to show that the reduction of acetophenones
to give dehalogenated products by Saccharomyces cerevi-
siae occurs via hydride transfer from NADH or NADPH,
mediated by a dehydrogenase present in the cells, to the
carbonyl carbon of acetophenones rather than by elec-
tron transfer (Scheme 6) (24–29) or glutathione-depend-
ent (51) mechanisms.
In recent years, various microorganisms have been
used to reduce -haloacetophenones to the correspond-
ing alcohols in good yield and e.e. (Table 2). The po-
tentiality of the application of enantioselective microbial
reduction of -haloketones is high due to the access to
chiral epoxides (Scheme 4). The company Kaneka uses
dehydrogenases in form of whole cells for production of
(R)- and (S)-styrene oxides on a pilot plant scale (52).
Goswani et al. (30) found Pichia pinus SC 13864 and
Candida sonorensis SC 16117 in a screening involving
about 100 microorganisms. These microorganisms re-
duce ketone 13 to give (R)-14 and (S)-14, respectively,
thereby representing one approach for the construction
of the chiral centers of the corresponding epoxides
(Scheme 7).
Chartrain et al. (31) selected Hansenula subpelliculosa
MY 1552, Pichia delftensis MY 1568, Kluyveromyces marxi-
anus MY 1516, S. bayanus MY 1930, R. pilimanae ATCC
32762 and P. carsoni MY 1622 from twenty strains that
gave positive results for enantioselective bioreduction of
-haloketone 15 to (S)-16 (X = Cl) (Scheme 8). The alco-
hol that is obtained may be used as an intermediate in
the synthesis of an endothelin receptor antagonist (57).
Recently, we found that Rhodotorula glutinis CCT 2182
reduces 15 (X = Cl, Br and N3) to the corresponding al-
cohol (R)-16 in excellent yield and e.e. (58). The alcohols
(R)-16 are also intermediates in the synthesis of (R)-epi-
nephrine, (R)-norepinephrine and (R)-isoproterenol.
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Table 2. Bioreduction of -haloacetophenones 5a–d mediated by microorganisms
Entry Ketone Microorganism Alcohol Yield/% e.e./% Ref.
1 5a Sacharomyces cerevisiae (R)-6a 67 97 48,49
2 5b " (R)-6b 37 90 "
3 5c " (R)-6c 74 82 "
4 5d " (S)-12 32 73 35,36
5 5a Geotrichum sp. (S)-6a 65 75 53
6 5b " (S)-6b 86 87 "
7 5c " (S)-6c 15 94 "
8 5c Rhodotorula sp. AS2.2241 (R)-6c 20 >99 12
9 5a R. mucilaginosa CBS 2378 (R)-6a 88 >99 54
10 5b Cryptococcus macerans (R)-6b 80 100 55
11 5c " (R)-6c 95 93 "
12 5b Geotrichum candidum CCT 1805 (S)-6b 89 >99 56
13 5c " (S)-6c 99 90 "
14 5d " (S)-6d 96 >99 "
15 5b Rhodotorula glutinis CCT 2182 (R)-6a 98 92 "
16 5c " (R)-6c 97 >99 "




















The alcohol (R)-18 is an important intermediate in
the synthesis of Eliprodil® and may be obtained in ex-
cellent yield and e.e. by bioreduction of -chloroketone
17, mediated either by engineered cells (44) or by Rho-
dotorula glutinis (Scheme 9) (59). The alcohol (S)-18 is ob-
tained when Geotrichum candidum is used.
Fantoni et al. (54,60) identified several microorgan-
isms from their collection that reduced -haloacetophe-
nones 5, 19 and 21 in the presence of polymeric absorb-
ing resins, giving the corresponding alcohols in high
yield and e.e. The alcohols obtained, 20 and 22, may be
used as chiral building blocks for the preparation of -
and -adrenergic drugs such as Sertraline, Nifenalol and
Sotalol, via their epoxides (Scheme 10).
The drug Sotalol may also be prepared from (S)-1-
-(4-nitrophenylethanediol) 24 obtained in excellent yield
and e.e. by reduction of ketone 23 by Geotrichum sp.
(Scheme 11) (61).
Reduction of –Unsaturated Aldehydes
and Ketones
It is well established that –unsaturated alde-
hydes and ketones may be reduced with certain regio-
and stereoselectivity using whole cells, with the selectiv-
ity depending mainly on (i) the biocatalyst, (ii) the sub-
stitution pattern of the C=C bond, (iii) the reaction con-
ditions and (iv) the time of incubation. As such, the
choice of appropriate conditions can allow the selective
reduction of either the C=O or the C=C bond alone or
the reduction of both groups. In terms of whole cells,
baker’s yeast is still the most popular reducing microor-
ganism, mainly because of its availability and cheapness.
As depicted in Scheme 12, Fardelone et al. (62) exploited
the versatility of baker’s yeast to prepare -substituted-
-3-phenyl-1-propanols (26) through the asymmetric re-
duction of -substituted-cinnamaldehydes (25) in excel-
lent yields (up to 99 %) and enantiomeric excesses (>99
%). The control of the pH of the reaction mixture at 5.5
by adding CaCO3 was crucial to ensure good yields of
the products (Scheme 12). The chiral building blocks
were used in alternative synthesis routes for the produc-
tion of both L- and D-phenylalaninol.
Reduction of cyclic enones by whole cells has been
explored further. Shimoda et al. (63) found that Synecho-
coccus sp. PCC 7942, a cyanobacterium, reduces both the
endocyclic C=C bond of s-trans enones and the exocyclic
C=C bond of s-cis enones to the corresponding (S)-ke-
tones, under illumination (Scheme 13). It is worth-men-
tioning that Synechococcus sp. PCC 7942 cells have the
ability of catalyzing enantioselective reduction of s-trans
enones to (S)-ketones. They specifically act on s-trans

























































a: R = Br






















enones that lack substituents at the -position in relation
to the carbonyl group and only if the -substituent is a
relatively small group, like a methyl group.
Plant cells other than those of higher plants are also
suitable for enone reduction. For instance, cell cultures
of Riccia fruitans, a briophyte, were able to biotransform
the sterically hindered terpenoid (–)-(5R)-carvone, in a
stereoselective fashion (Scheme 14) (64). The enoate
reductase step of the reduction of (–)-(5R)-carvone (29)
to (+)-n-dihydrocarvone (30) and the ensuing alcohol
dehydrogenase step yielding neo-dihydrocarveol (31)
both occurred with high diastereoselectivity.
The work of Siqueira-Filho et al. represents signifi-
cant progress in the field of stereoselective biotransfor-
mation of -methylene ketones (65,66). Again, baker’s
yeast was the biocatalyst of choice in a systematic study
of the effect on the reaction profile of the substituents
attached to the enone group. As expected, the reduction
of C=C bond by enoate reductase enzymes was much
faster than the reduction of the C=O bond by carbonyl
reductase enzymes. Ultimately, only the substrate 32
bearing a small methyl group attached to the carbonyl
was satisfactorily reduced to the corresponding satu-
rated (R)-ketone 33 in good yields and e.e.’s (up to >99
%) (Scheme 15).
A bottleneck in biotransformations with whole cells
is the presence of multiple competing enzymes, which
reduces or suppresses both the formation of the desired
product and the stereoselectivity of the reaction. In the
past years, the hydrophobic polymer method has pre-
sented itself as a good tool to harness the potential of
multiple enzymes acting on the same substrate. For in-
stance, Conceição et al. (67) circumvented the cumber-
some reduction of -methylene ketone 34 by the yeast
Pichia stipitis CCT 2617 using Amberlite XAD-7 as ad-
sorbing resin (Scheme 16). The formation of by-products
and the pronounced toxic effect of the substrate on the
biocatalyst were suppressed through the slow release of
the substrate, which was adsorbed on the beads of
XAD-7, into the aqueous reaction medium. Low concen-
tration of the substrate in the aqueous phase favored the
action of the most active enzyme, a carbonyl reductase
that delivered (S)-allylic alcohol 35 in high yield and e.e.
(>99 %).
Amberlite XAD-7 was also exploited in the reduc-
tion of the same -methylene ketone 34 by the yeast
Rhodotorula glutinis CCT 2182 (Scheme 16) (68). The low
yield and moderate enantiomeric excess of the product
were dramatically changed when XAD-7 was used to
control the concentration of the enone in the aqueous
phase. As a result, the corresponding (S)--methylke-
tone 36 was isolated in high yield and e.e. (99 %).
Conclusion
The past few years have witnessed significant de-
velopments in the field of biocatalytic reduction of ace-
tophenones and -unsaturated carbonyl compounds.
High efficiency of these processes makes them attractive
alternatives to existing methods in asymmetric catalysis
for obtaining highly functionalized chiral alcohols and
ketones in enantiomerically pure form.
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Napredak u biokataliti~koj asimetri~noj redukciji acetofenona i
-nezasi}enih karbonilnih spojeva
Sa`etak
Cijele stanice `ivih organizama, posebice stanice kvasaca, koristile su se kao pouzdani
biokatalizatori pri provo|enju redoks-reakcija raznih funkcionalnih skupina. U radu se po-
sebna pozornost posvetila mogu}nostima tih cijelih stanica za redukciju acetofenona i
-nezasi}enih karbonilnih spojeva (aldehida i ketona) proizvode}i relevantne kiralne
spojeve za proizvodnju finih kemikalija i za potrebe farmaceutske industrije.
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